Cargando…

Body Weight as a Determining Factor in the Predominance of Adverse Drug Reactions Induced by Fixed-Dose Adalimumab Injections in Female Patients in a Korean Hospital Setting

Adalimumab is used at 40-mg dose to treat systemic inflammatory diseases. Given the impact of adverse drug reactions (ADRs), which particularly result in the discontinuation of adalimumab therapy in female patients, this study examined whether sex affects the frequency and type of ADRs induced by ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kwi Suk, Choi, Young Hee, Moon, Aree, Kim, Sang Geon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074186/ https://www.ncbi.nlm.nih.gov/pubmed/32046138 http://dx.doi.org/10.3390/jcm9020461

Ejemplares similares

Addition of Cyclosporine to Adalimumab Improved Psoriasis And Adalimumab-Induced Injection Site Reaction
por: Nakamizo, Satoshi, et al.
Publicado: (2014)

Efficacy of Adalimumab in Korean Patients with Crohn’s Disease
por: Sohn, Il Woong, et al.
Publicado: (2016)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients
por: Jin, Hyun Jung, et al.
Publicado: (2020)

Adalimumab induced pulmonary sarcoid reaction
por: Bhargava, S., et al.
Publicado: (2013)

Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database
por: Maity, Tuhin, et al.
Publicado: (2021)

Frequency of peripheral diseases in Korean patients with ankylosing spondylitis and the effectiveness of adalimumab
por: Lee, Sang‐Hoon, et al.
Publicado: (2020)

Accreditation standards items of post-2nd cycle related to the decision of accreditation of medical schools by the Korean Institute of Medical Education and Evaluation
por: Park, Kwi Hwa, et al.
Publicado: (2023)

The effects of intravitreal adalimumab injection on pseudophakic macular edema
por: Farvardin, Mohsen, et al.
Publicado: (2020)

Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study)
por: Kim, Dong Hyun, et al.
Publicado: (2023)

Severe Adverse Drug Reactions in Korean Elderly Patients
por: Lee, Jungun
Publicado: (2022)

Long-term Outcomes of Adalimumab Therapy in Korean Patients with Ulcerative Colitis: A Hospital-Based Cohort Study
por: Oh, Eun Hye, et al.
Publicado: (2020)

Incidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactions
por: Zitha, Eddy, et al.
Publicado: (2014)

Treatment of Recalcitrant Pyoderma Gangrenosum with Ulcerative Colitis by Adalimumab Injection
por: Lee, Jin-Hyup, et al.
Publicado: (2017)

Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases
por: Choi, Young Hee, et al.
Publicado: (2019)

Real-world effectiveness and safety of adalimumab in Korean patients with intestinal Behcet’s disease: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter study
por: Lee, Seung Bum, et al.
Publicado: (2023)

Adverse drug reaction after intravitreal injection of topotecan
por: Narang, Subina, et al.
Publicado: (2020)

Predominant HLA Alleles and Haplotypes in Mild Adverse Drug Reactions Caused by Allopurinol in Vietnamese Patients with Gout
por: Van Son, Chu, et al.
Publicado: (2021)

Epidural Steroid Injection in Korean Pain Physicians: A National Survey
por: Kim, Eun Jung, et al.
Publicado: (2014)

Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
por: Jung, Yoon Suk, et al.
Publicado: (2021)

The Severe Adverse Reaction to Vitamin K(1) Injection Is Anaphylactoid Reaction but Not Anaphylaxis
por: Mi, Yan-Ni, et al.
Publicado: (2014)

Anti-TNF (adalimumab) injection for the treatment of adults with frozen shoulder during the pain predominant stage protocol for a multi-centre, randomised, double blind, parallel group, feasibility trial
por: Hopewell, Sally, et al.
Publicado: (2023)

Development of an adverse events reporting form for Korean folk medicine
por: Park, Jeong Hwan, et al.
Publicado: (2016)

Capsaicin cough sensitivity is related to the older female predominant feature in chronic cough patients
por: Song, Woo-Jung, et al.
Publicado: (2014)

Severe Cutaneous Adverse Reactions in Korean Pediatric Patients: A Study From the Korea SCAR Registry
por: Oh, Hea Lin, et al.
Publicado: (2019)

Vitiligo during Treatment of Crohn's Disease with Adalimumab: Adverse Effect or Co-Occurrence?
por: Posada, Celia, et al.
Publicado: (2011)

Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn’s Disease
por: Ogata, Haruhiko, et al.
Publicado: (2016)

Adverse Reaction Following the Subarachnoid Injection of Xylazine in a Sheep
por: Pratt, Shaun, et al.
Publicado: (2022)

Paradoxical Reaction in a Patient with Hidradenitis Suppurativa Undergoing Adalimumab Treatment
por: IKEYA, Soichiro, et al.
Publicado: (2021)

Age-related trends in injection site reaction incidence induced by the tumor necrosis factor-α (TNF-α) inhibitors etanercept and adalimumab: the Food and Drug Administration adverse event reporting system, 2004-2015
por: Matsui, Toshinobu, et al.
Publicado: (2017)

Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability
por: Navarro-Millán, Iris, et al.
Publicado: (2016)

Uncommon Female-Predominant Etiologies of Cryptogenic Stroke
por: Dong, Jing, et al.
Publicado: (2022)

Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study
por: Han, Minkyung, et al.
Publicado: (2020)

Atypical Mycobacterial Tenosynovitis in the Setting of Adalimumab Use
por: Patel, Jay, et al.
Publicado: (2021)

Cutaneous adverse drug reactions with fixed-dose combinations: Special reference to self-medication and preventability
por: Tripathy, Ratikanta, et al.
Publicado: (2018)

A Case of Adalimumab-Induced Psoriasiform Dermatitis in an Ankylosing Spondylitis Patient: Unusual Progression after Adalimumab Retreatment
por: Yoon, Ji Ha, et al.
Publicado: (2022)

Treatment of Hidradenitis Suppurativa Patient with Klinefelter Syndrome by Adalimumab
por: Shin, Ji Yeoun, et al.
Publicado: (2019)

Differences between Drug-Induced and Contrast Media-Induced Adverse Reactions Based on Spontaneously Reported Adverse Drug Reactions
por: Ryu, JiHyeon, et al.
Publicado: (2015)

Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
por: Jiang, Yijia, et al.
Publicado: (2023)

Lessons learnt from a discontinued randomised controlled trial: adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica (Subcutaneous Injection of Adalimumab Trial compared with Control: SCIATiC)
por: Williams, Nefyn H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rtkcbdo4jrt9qqk8dmtht8e4gm